UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results of the randomized JO25567 study

Lung cancer (Amsterdam, Netherlands), 2021-01, Vol.151, p.20-24

2021

Volltextzugriff (PDF)

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Annals of oncology, 2007-02, Vol.18 (2), p.317-323

2007

Volltextzugriff (PDF)

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

Annals of oncology, 2013-01, Vol.24 (1), p.20-30

2013

Volltextzugriff (PDF)

Migratory bone lesions in lymphoma

QJM : An International Journal of Medicine, 2022-03, Vol.115 (3), p.177-178

2022

Volltextzugriff (PDF)

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

British journal of cancer, 2008-03, Vol.98 (5), p.907-914

2008

Volltextzugriff (PDF)

Biomechanical comparison of titanium alloy additively manufactured and conventionally manufactured plate-screw constructs

New Zealand veterinary journal, 2024-01, Vol.72 (1), p.17-27

2024

Volltextzugriff (PDF)

EGFR mutation in gefitinib-responsive small-cell lung cancer

Annals of oncology, 2006-06, Vol.17 (6), p.1028-1029

2006

Volltextzugriff (PDF)

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402)

Annals of oncology, 2012-09, Vol.23 (9), p.2253-2258

2012

Volltextzugriff (PDF)

Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer

British journal of cancer, 2013-04, Vol.108 (7), p.1488-1494

2013

Volltextzugriff (PDF)

The dynamics of granular flow from a silo with two symmetric openings

Proceedings of the Royal Society. A, Mathematical, physical, and engineering sciences, 2019-01, Vol.475 (2221), p.20180462-20180462

2019

Volltextzugriff (PDF)

Corrigendum: The Risky Closed Economy: A Holistic, Longitudinal Approach to Studying Fear and Anxiety in Rodents

Frontiers in behavioral neuroscience, 2021-04, Vol.15, p.684179-684179

2021

Volltextzugriff (PDF)

Identification of thymidylate synthase as a potential therapeutic target for lung cancer

British journal of cancer, 2010-07, Vol.103 (3), p.354-361

2010

Volltextzugriff (PDF)

Contrasting Episodes of Regional Granulite-Facies Metamorphism in Enclaves and Host Gneisses from the Aravalli–Delhi Mobile Belt, NW India

Journal of petrology, 2008-01, Vol.49 (1), p.107-128

2008

Volltextzugriff (PDF)

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer

Annals of oncology, 2017-02, Vol.28 (2), p.285-291

2017

Volltextzugriff (PDF)

Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Japanese patients with solid malignant tumors

Annals of oncology, 2003-06, Vol.14 (6), p.922-930

2003

Volltextzugriff (PDF)

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status

British journal of cancer, 2008-02, Vol.98 (4), p.749-755

2008

Volltextzugriff (PDF)

Serum biomarkers during the first cycle of anti-PD-1 antibody therapies in non-small cell lung cancer

Annals of oncology, 2018-10, Vol.29, p.viii427-viii427

2018

Volltextzugriff (PDF)

Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs

British journal of cancer, 2010-06, Vol.103 (1), p.36-42

2010

Volltextzugriff (PDF)

Population pharmacokinetics of erlotinib in Japanese patients with advanced non-small cell lung cancer

Journal of clinical pharmacy and therapeutics, 2015-04, Vol.40 (2), p.232-239

2015

Volltextzugriff (PDF)

An early survey of the radioactive contamination of soil due to the Fukushima Dai-ichi Nuclear Power Plant accident, with emphasis on plutonium analysis

GEOCHEMICAL JOURNAL, 2012/08/20, Vol.46(4), pp.341-353

2012

Volltextzugriff (PDF)

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

British journal of cancer, 2003-02, Vol.88 (3), p.335-341

2003

Volltextzugriff (PDF)

The Risky Closed Economy: A Holistic, Longitudinal Approach to Studying Fear and Anxiety in Rodents

Frontiers in behavioral neuroscience, 2020-10, Vol.14, p.594568-594568

2020

Volltextzugriff (PDF)

9LBA Antitumor activity of ASP8273, an irreversible mutant selective EGFR-TKI, in NSCLC patients with tumors harboring EGFR activating mutations and T790M resistance mutation

European journal of cancer (1990), 2014-11, Vol.50, p.198-198

2014

Volltextzugriff (PDF)

29 TAS-114 is a novel dUTPase/DPD inhibitor, its DPD inhibition reduces capecitabine dosage but does not diminish therapeutic window in human tumor xenografts

European journal of cancer (1990), 2014-11, Vol.50, p.15-15

2014

Volltextzugriff (PDF)

P-159 Impact of the symbiotic metabolites D-amino acids on preimplantation development

Human reproduction (Oxford), 2023-06, Vol.38 (Supplement_1)

2023

Volltextzugriff (PDF)

1 – 25 von 4.837

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.601)
Mit Volltextzugriff
(4.189)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.608)
Life Sciences & Biomedicine
(2.069)
Biological And Medical Sciences
(954)
Humans
(927)
Male
(774)
Physical Sciences
(658)
Female
(657)
Agriculture
(604)
Fundamental And Applied Biological Sciences. Psychology
(507)
Middle Aged
(504)
Medical Sciences
(465)
Animals
(447)
Aged
(435)
Chemistry
(410)
Adult
(404)
Agriculture, Multidisciplinary
(389)
Biochemistry & Molecular Biology
(305)
Physics
(267)
Exact Sciences And Technology
(263)
Food Science & Technology
(260)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results of the randomized JO25567 study

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

Migratory bone lesions in lymphoma

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

Biomechanical comparison of titanium alloy additively manufactured and conventionally manufactured plate-screw constructs

EGFR mutation in gefitinib-responsive small-cell lung cancer

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402)

Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer

The dynamics of granular flow from a silo with two symmetric openings

Corrigendum: The Risky Closed Economy: A Holistic, Longitudinal Approach to Studying Fear and Anxiety in Rodents

Identification of thymidylate synthase as a potential therapeutic target for lung cancer

Contrasting Episodes of Regional Granulite-Facies Metamorphism in Enclaves and Host Gneisses from the Aravalli–Delhi Mobile Belt, NW India

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer

Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Japanese patients with solid malignant tumors

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status

Serum biomarkers during the first cycle of anti-PD-1 antibody therapies in non-small cell lung cancer

Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs

Population pharmacokinetics of erlotinib in Japanese patients with advanced non-small cell lung cancer

An early survey of the radioactive contamination of soil due to the Fukushima Dai-ichi Nuclear Power Plant accident, with emphasis on plutonium analysis

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

The Risky Closed Economy: A Holistic, Longitudinal Approach to Studying Fear and Anxiety in Rodents

9LBA Antitumor activity of ASP8273, an irreversible mutant selective EGFR-TKI, in NSCLC patients with tumors harboring EGFR activating mutations and T790M resistance mutation

29 TAS-114 is a novel dUTPase/DPD inhibitor, its DPD inhibition reduces capecitabine dosage but does not diminish therapeutic window in human tumor xenografts

P-159 Impact of the symbiotic metabolites D-amino acids on preimplantation development

Suchergebnisse filtern